• Saffron Therapeutics
  • Saffron Therapeutics
  • Saffron Therapeutics

Message from Corporate

Since our inception, in Sep 2014 Saffron Therapeutics has been incorporated as a 100 percent Domestic Focused Branded Business Unit (DBBU). These formative years have seen us evolve as strong player in the field of Gastroenterology & ENT Speciality offering competition to already established pharmaceutical companies.

A clear strategic focus, value chain integration, product versatility, state-of-the-art infrastructure and an empowered organisation constitute the key elements of our growth model.

The strategic and structural transformation achieved by us has propelled the company into new horizons of growth. We have always countered challenges successfully with our operational efficiency and best management of Human Capital. Talent management and talent transformation hold the key to Saffron’s business development. The remarkable transformation over the years has been in no small measure which has been made possible due to the team effort within the organisation.

As always, people at Saffron are and would make the positive difference in the quest towards achieving higher levels of growth and profitability in the years to come. We also believe that transparency in sharing of information goes a long way in strengthening the relationship between the stakeholders and the company.

We hope this website helps you in identifying your requirements and is useful in presenting an insight into our organisation’s service capabilities and aspirations.